The largest prospective warfarin-treated cohort supports genetic forecasting
about
Optimal loading dose of warfarin for the initiation of oral anticoagulationOptimal loading dose of warfarin for the initiation of oral anticoagulationCYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosingThe pharmacogenomics of pain management: prospects for personalized medicineClopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Pharmacogenomics and cardiovascular diseaseInfluence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysisPharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumonPharmacogenetics-based warfarin dosing in childrenClinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosingEffects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysisImpact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysisEffect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarinEffect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysisWarfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groupsA genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin doseTherapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north IndiansHigh-dimensional pharmacogenetic prediction of a continuous trait using machine learning techniques with application to warfarin dose prediction in African AmericansGenetic testing of inherited arrhythmias.Riociguat (BAY 63-2521) and warfarin: a pharmacodynamic and pharmacokinetic interaction study.10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.Rapid genotyping of single nucleotide polymorphisms influencing warfarin drug response by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry.Integration of genetic, clinical, and INR data to refine warfarin dosing.Optimal loading dose for the initiation of warfarin: a systematic reviewEthnicity-specific pharmacogenetics: the case of warfarin in African AmericansGastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcomeGenetic risk factors for major bleeding in patients treated with warfarin in a community setting.Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testingApplied pharmacogenomics in cardiovascular medicinePharmacogenomics: Current State-of-the-ArtPrescribing warfarin appropriately to meet patient safety goals.Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications.Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population.Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Characterizing variability in warfarin dose requirements in children using modelling and simulation.Pharmacogenetics of anticoagulants.Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.
P2860
Q24202077-91D11F72-4678-4922-A8D3-8A06AC9FCF14Q24236138-BA70B8BD-94EF-4873-A64B-7E0724367978Q24641999-25F0D1CB-1867-49E2-B3DA-DE51C4E85987Q26765266-92221547-4EC1-4BE0-89D6-11188957C8D2Q26823542-4B515A2F-7AF4-49D0-9E2D-9266A0B8623BQ26997380-EB755040-37D9-4C5F-8A46-F126F81CC8E2Q27002899-CE18BE8D-BADB-4024-949C-A51EFFD2946AQ27006860-2FA9066D-7C3A-44B9-B0CF-53DC003CB153Q27008320-9A9555F1-48BC-4C2B-ADF8-286BE23CF47CQ27008360-ABD284E3-EB6D-46B0-AB1E-0C2B73628F76Q27026134-E9C36C13-1768-45AF-BBB6-163F0DB79703Q28071310-80A7C9D2-2670-4B68-AFD5-DFB41E98A6E6Q28276514-E23DE0C7-D7D6-4C5C-B997-557E628878B9Q28276605-9D0D3E8A-7DC5-4862-80AD-6C984F347846Q28395337-843B5238-E829-46D4-AAA0-70CF9C46AF2DQ28475004-0D6862C7-75A7-43C2-A798-93AFB025372FQ28483861-455723EB-C143-454D-8B80-49A473876172Q28740452-CE0A7B2B-37DA-445B-8294-23F7E8F05139Q33161113-732F8518-1676-4D0F-ACFC-535E02A87EEDQ33447738-3505F1BD-A9EF-43C2-8DEB-17D17895D0FFQ33517162-6EFF4DAB-4A55-4A9A-9D58-A025955DEE5AQ33523960-D84E4827-A56B-41DF-8AAC-B56992C6309AQ33550741-40A4A12F-98B3-455A-AB7C-0C459D42A4A3Q33559159-644BDB2A-7A5A-426C-B147-C8E007A68E39Q33591111-E6C38CE5-0B82-4DC7-B16F-8EA1378C9080Q33760056-44956F83-90AB-46CD-AA38-A5EA09BEDE0DQ33792352-1FF79664-BBCC-4475-86FB-114F20F27C22Q33813830-4F1B48EC-C19B-4B00-8852-E0403F1E6D49Q33846255-384A69F7-7684-4FA0-BEA5-97F976ECE146Q33891714-333CF4D5-3252-46DD-8879-9C9ACA0A7AB0Q33932089-894E23C6-ED4A-4091-AD12-6D80ACDE0AE4Q33943678-4F5A4CD7-06EC-48F4-9F8E-580A05CD6EDFQ33946309-241E7D60-D4C8-4FEE-8C0B-BCBAF54CE07BQ34065133-28A742A7-5B3B-4D97-A14E-4A0290C0C255Q34085379-EE0B0329-736B-448D-A254-DA88B534B38AQ34096562-0CC707F3-DA30-406C-A73D-B9F0D77F5380Q34131354-F0151D09-FB1D-4A97-9A46-79734565DEEBQ34209582-847FB296-330A-4CE4-885A-245001C42D9BQ34219746-6E12609C-275F-4A97-98F5-4426FEF50CDEQ34362277-94104B54-073D-4B18-9963-42201221E7F0
P2860
The largest prospective warfarin-treated cohort supports genetic forecasting
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The largest prospective warfarin-treated cohort supports genetic forecasting
@en
The largest prospective warfarin-treated cohort supports genetic forecasting.
@nl
type
label
The largest prospective warfarin-treated cohort supports genetic forecasting
@en
The largest prospective warfarin-treated cohort supports genetic forecasting.
@nl
prefLabel
The largest prospective warfarin-treated cohort supports genetic forecasting
@en
The largest prospective warfarin-treated cohort supports genetic forecasting.
@nl
P2093
P2860
P1433
P1476
The largest prospective warfarin-treated cohort supports genetic forecasting
@en
P2093
Anders Rane
Jonatan D Lindh
Lennart Holm
Leslie Y Chen
Mohammed J R Ghori
Niclas Eriksson
Ralph McGinnis
Suzannah Bumpstead
P2860
P304
P356
10.1182/BLOOD-2008-04-149070
P407
P577
2008-06-23T00:00:00Z